Clinical trial
The Evaluation of Patients With Acute Hypertension and Intracerebral Hemorrhage With Intravenous Clevidipine Treatment (ACCELERATE)
NCT00666328 is registered in ClinicalTrials.gov with The Medicines Company as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Evaluation of Patients With Acute Hypertension and Intracerebral Hemorrhage With Intravenous Clevidipine Treatment (ACCELERATE)
- Lead sponsor
- The Medicines Company
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- June 30, 2008
- Completion date
- April 30, 2010
- Enrollment
- 37 (actual)
- Sites
- 17
Conditions
As the registry lists them; a condition with its own page is linked.